As of February 2026 Samsung Biologics has a market cap of C$72.02 Billion. This makes Samsung Biologics the world's 458th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.